Category: Capitol Hill
Senator Joe Donnelly (D-Ind.) asks new Senate Finance Committee Chairman Ron Wyden (D-Ore.) to join in fighting to repeal the medical device tax.
Senator Joe Donnelly (D-Ind.) is hoping to garner the support of new Senate Finance Committee Chairman Ron Wyden (D-Ore.) in efforts to repeal the medical device tax.
In an open letter issued yesterday, Donnelly congratulated Wyden on his new role and voiced concerns that the medtech tax is hurting American innovation.
A bill to repeal the medical device tax sponsored by Sen. Orrin Hatch (R-Utah) advances to the Senate Finance Committee.
A bill aiming to repeal the medical device tax sponsored by Sen. Orrin Hatch (R-Utah) is before the Senate Finance Committee.
The bill was read in and sent to the finance panel Feb. 7, 2013. It would strike all references to the 2.3% excise tax on medical devices enacted as part of the Affordable Care Act from the federal tax code.*
Rep. Erik Paulsen (R-Minn.) urges President Barack Obama ahead of Minnesota visit to take mercy on medical device makers, which have faced layoffs and R&D cuts in the wake of the 2.3% medical device tax.
President Barack Obama is slated next month to make a visit to one of the medical device industry's primary hubs in Minnesota, and medtech advocates are hoping to use the occasion to emphasize efforts to repeal a 2.3% sales tax that hit the industry last year.
What can the medtech industry expect from Sen. Ron Wyden on the medical device tax as he takes over the Senate Finance Committee from Sen. Max Baucus?
With Sen. Max Baucus (D-Mont.) on the road to China, Sen. Ron Wyden (D-Ore.) is slated to take over the 2nd-most-powerful post in the U.S. Senate.
The senior senator from Oregon is considered to be a pragmatic dealmaker, winning praise from both sides of the aisle. That could augur well for proponents of repealing the 2.3% medical device tax enacted as part of the Affordable Care Act.
More conflict-of-interest scandals rock the high-profile National Quality Forum as group president & CEO Cristine Cassel faces questions about outside compensation she received following her appointment.
Dr. Cristine Cassel, President and CEO of the National Quality Forum, speaking before the Senate Committee on Health, Education, Labor, & Pensions. Dr. Cassel was paid hundreds of thousands of dollars in additional outside compensation after she was hired in December 2012. (help.senate.gov)
by Marshall Allen, ProPublica
A trio of U.S. senators introduces a bill that would strip the FDA's oversight of low-risk health IT such as smartphone apps or electronic medical records systems.
A new bill introduced this week by a bipartisan trio of U.S. senators would remove low-risk health information technology from the FDA's purview – and from the 2.3% medical device tax imposed under the Affordable Care Act.
Sens. Deb Fischer (R-Neb.), Angus King (D-Maine) and Marco Rubio (R-Fla.) co-sponsored the Preventing Regulatory Overreach to Enhance Care Technology (PROTECT) Act, introducing the measure on the Senate floor Feb. 10.